MALAT1 and cancer: The ASO strategy is promising for cancer therapy; for example, Gone et al. recently showed that a ASO-conjugated nanostructure targeting MALAT1 can be used to efficiently knockdown the expression of this lncRNA in the nucleus, thus reducing cell migration in lung cancer, providing a promising strategy for controlling tumor metastasis [69].